In our clinic, we are seeing more and more women of reproductive age using marijuana in various forms. According to research published in the Journal of the American Medical Association, there has been a significant [...]
And it’s also Maternal Mental Health Awareness Week (April 30 to May 4). Many different organizations around the world are coming together to increase awareness of and decrease the stigma surrounding perinatal mood and anxiety [...]
The American College of Obstetricians and Gynecologists (ACOG) has made a significant change to its recommendations for optimal postpartum care. Previously, ACOG has recommended that women receive a single, comprehensive postpartum visit within the first [...]
Women with bipolar disorder are vulnerable to postpartum illness, and it is generally recommended that mothers continue treatment with a mood stabilizer throughout the postpartum period to reduce their risk of relapse; however, this recommendation [...]
In the field of reproductive psychiatry, we don’t really have any textbooks to rely on. However, the June issue of the Psychiatric Clinics of North America is devoted to Women’s Mental Health, and it’s pretty [...]
The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: November 1, 2016 By: Gerald G. Briggs, BPharm, FCCP, Christina Chambers, PhD, MPH, Lee S. Cohen, MD, & Gideon Koren, MD Editor’s note: As [...]
Some good news for women with perinatal mood and anxiety disorders... Today, the U.S. House of Representatives passed the Bringing Postpartum Depression Out of the Shadows Act to provide federal grants to develop and maintain [...]
Ms. C is a woman with a long history of bipolar disorder, dating back to her teen years. Because she experienced recurrent hypomania and mania every time she attempted to discontinue her treatment, she and [...]
Women with bipolar disorder are at a higher risk for relapse during pregnancy and that the risk is even higher during the postpartum period. In addition, women with bipolar disorder are more vulnerable to postpartum [...]
The U.S. Food and Drug Administration (FDA) has proposed major revisions to prescription drug labeling in order to provide more accurate and helpful information on the effects of medications used during pregnancy and breastfeeding. [...]